Cluster Of Differentiation (CD) 79a Antibody Global Market Report 2025
상품코드:1889338
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
CD79a 항체 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 11억 1,000만 달러로 평가되었고, 2025년에는 12억 2,000만 달러에 달할 것으로 추정되며, CAGR 10.7%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 림프종 및 백혈병 증례 증가, 진단용 면역조직 화학검사 수요 증가, 암 조기 발견에 대한 의식 향상, 단일클론 항체의 임상 채용 급증, 병원 및 진단 실험실 인프라 확충, 질환 특정에 있어서 바이오마커 이용 증가 등이 요인이 되고 있습니다.
CD79a 항체 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 18억 1,000만 달러에 달할 것으로 예측되며, CAGR 10.3%로 성장할 전망입니다. 예측 기간의 성장 요인으로는 혈액 악성 종양의 발생률 상승, 헬스 케어 지출 증가, 맞춤형 치료 접근법에 대한 주목 증가, 표적 요법에 관한 임상 조사 연계 급증, 면역 종양학 임상시험 확대, 항체 기반 진단 검사의 선호도 향상 등을 들 수 있습니다. 예측 기간 주요 동향으로는 항체 공학 및 정제 기술의 진보, 면역 측정 플랫폼 개발의 진전, 항체 결합 및 표지법의 혁신, 자동화 진단 기기의 개발, 차세대 단일클론 항체 제제의 연구 개발, 항체 검증을 위한 바이오인포매틱스 툴의 혁신 등을 들 수 있습니다.
표적 치료제에 대한 수요 증가는 향후 CD79a 항체 시장의 성장을 가속할 것으로 예측됩니다. 표적 치료란 암이나 기타 질환에서 분자적 이상을 특이적으로 표적화하고 억제함으로써 치료의 정확성을 높이고 건강한 세포에 대한 손상을 최소화하는 치료법입니다. 표적 치료에 대한 주목도가 높아지고 있는 주요 요인은 정밀의료의 진보에 있습니다. 정밀의료는 개인의 유전자 프로파일을 기반으로 개인화하고 보다 효과적인 치료를 가능하게 합니다. CD79a 항체는 B 세포 마커에 특이적으로 결합하여 표적 요법을 지원하며 혈액 악성 종양에서 정밀 치료에 적합합니다. 암화된 B 세포를 선택적으로 표적화함으로써 치료 효과를 높이고, 환자의 결과를 개선하며, 오프타겟 효과를 최소화합니다. 예를 들어, 미국 비영리 의료 과학 단체인 미국 유전자 세포 치료 학회(ASGCT)에 따르면 2024년 12월 현재 식품 의약국(FDA)은 2023년 6건의 유전자 치료 제품을 승인했습니다. 이는 2022년 5건에서 증가했습니다. 따라서, 표적 치료제에 대한 수요 증가는 분화 클러스터 CD79a 항체 시장의 성장을 이끌고 있습니다.
분화 클러스터 CD79a 항체 시장에서 사업을 전개하는 주요 기업은 연구 가속화, 데이터 품질 향상, 수작업으로 워크플로우의 복잡화 완화를 목적으로 유연한 다중 면역조직화학(IHC) 분석 등의 선진적 솔루션 개발에 주력하고 있습니다. 유연한 멀티플렉스 IHC는 단일 조직 샘플에서 여러 바이오마커를 동시에 감지하면서 공간적 맥락을 유지하는 첨단 실험 기술을 말합니다. 예를 들어 2023년 9월 미국 바이오테크놀러지 기업 셀 시그널링 기술(CST)은 SignalStar 멀티플렉스 IHC 플랫폼을 발표했습니다. 이 공간 생물학 솔루션은 유연한 항체 기반 플랫폼으로, 최대 8중 증폭을 2일 동안 실현하는 고다중 실험을 가능하게 합니다. 통합된 패널 설계 지원과 최적화된 프로토콜을 갖추고 있어 대규모 최적화 없이 원활하게 바이오마커 감지 및 데이터 생성이 가능합니다. 조직 기반 분석에서 진단 정확도, 처리량 및 공간 분해능을 향상시키고 CD79a 항체 분야에서 중요한 진보를 보여줍니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 CD79a 항체 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 CD79a 항체 시장 : 성장률 분석
세계의 CD79a 항체 시장 실적 : 규모 및 성장(2019-2024년)
세계의 CD79a 항체 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 CD79a 항체 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 CD79a 항체 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
단일클론 항체
폴리클로날 항체
재조합 항체
세계의 CD79a 항체 시장 : 기술별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
웨스턴 블로팅
면역조직화학
플로우 사이토메트리
효소 면역 측정법(ELISA)
세계의 CD79a 항체 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
직접 판매
리셀러
온라인 판매
세계의 CD79a 항체 시장 : 최종 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
바이오테크놀러지 기업
제약 기업
학술연구기관
진단 실험실
세계의 CD79a 항체 시장 : 단일클론항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
마우스 유래 항체
토끼 유래 항체
인간 유래 항체
키메라 항체
인간화 항체
세계의 CD79a 항체 시장 : 폴리클로날 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
염소 유래 항체
토끼 유래 항체
양 유래 항체
당나귀 유래 항체
말 유래 항체
세계의 CD79a 항체 시장 : 재조합 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
싱글 체인 가변 영역 항체
단편 항원 결합 항체
이중특이적 항체
나노 바디
설계된 전장 항체
제7장 지역별 및 국가별 분석
세계의 CD79a 항체 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 CD79a 항체 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
CD79a 항체 시장 : 경쟁 구도
CD79a 항체 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Becton, Dickinson and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Bio-Rad Laboratories Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bio-Techne Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Miltenyi Biotec BV & Co. KG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
GenScript Biotech Corporation
Cell Signaling Technology Inc.
Sino Biological Inc.
Proteintech Group Inc.
Santa Cruz Biotechnology Inc.
OriGene Technologies Inc.
GeneTex Inc.
Abnova Corporation
RayBiotech Life Inc.
Wuhan Fine Biotech Co. Ltd.(commonly known as FineTest)
Aviva Systems Biology Corporation
EXBIO Praha as
NSJ Bioreagents Inc.
Boster Biological Technology Co. Ltd.
Bioss Antibodies Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
CD79a 항체 시장(2029년) : 새로운 기회를 제공하는 국가
CD79a 항체 시장(2029년) : 새로운 기회를 제공하는 부문
CD79a 항체 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Cluster of differentiation (CD) 79a antibody is a monoclonal antibody that targets the CD79a protein, a component of the B cell antigen receptor complex found on the surface of B lymphocytes. Its primary purpose is to identify and study B cell lineage in research and diagnostic applications. It plays an important role in distinguishing B cell neoplasms from other hematologic disorders and is also used to examine B cell development and function in immunological and pathological studies.
The main product types of cluster of differentiation (CD) 79a antibody are monoclonal antibodies, polyclonal antibodies, and recombinant antibodies. Monoclonal antibodies are laboratory produced molecules created to bind specifically to the CD79a protein on B cells, reflecting the immune system's ability to target harmful pathogens or diseased cells. It uses various technologies such as western blotting, immunohistochemistry, flow cytometry, and enzyme linked immunosorbent assay (ELISA), and is distributed through multiple channels including direct sales, distributors, and online sales. Key end uses include biotechnology companies, pharmaceutical companies, academic and research institutes, and diagnostic laboratories.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The cluster of differentiation (CD) 79a antibody market research report is one of a series of new reports from The Business Research Company that provides cluster of differentiation (CD) 79a antibody market statistics, including the cluster of differentiation (CD) 79a antibody industry global market size, regional shares, competitors with the cluster of differentiation (CD) 79a antibody market share, detailed cluster of differentiation (CD) 79a antibody market segments, market trends, and opportunities, and any further data you may need to thrive in the cluster of differentiation (CD) 79a antibody industry. This cluster of differentiation (CD) 79a antibody market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cluster of differentiation (CD) 79a antibody market size has grown rapidly in recent years. It will grow from $1.11 billion in 2024 to $1.22 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rising prevalence of lymphoma and leukemia cases, increasing demand for diagnostic immunohistochemistry, growing awareness of early cancer detection, surge in clinical adoption of monoclonal antibodies, expansion of hospital and diagnostic laboratory infrastructure, and rising use of biomarkers in disease identification.
The cluster of differentiation (CD) 79a antibody market size is expected to see rapid growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to rising incidence of hematological malignancies, increasing healthcare expenditure, growing focus on personalized therapeutic approaches, surge in clinical research collaborations for targeted therapies, expansion of immuno oncology clinical trials, and rising preference for antibody based diagnostic testing. Major trends in the forecast period include technological advancements in antibody engineering and purification, progress in immunoassay platform development, innovations in antibody conjugation and labeling methods, developments in automated diagnostic instrumentation, research and development in next generation monoclonal antibody formulations, and innovations in bioinformatics tools for antibody validation.
The increasing demand for targeted therapeutics is expected to propel the growth of the cluster of differentiation CD 79a antibody market going forward. Targeted therapies are treatments that specifically target and inhibit molecular abnormalities in cancer or other diseases to improve treatment precision and minimize harm to healthy cells. The rising focus on targeted therapies is primarily driven by advancements in precision medicine, which enables personalized and more effective treatments based on individual genetic profiles. CD79a antibodies support targeted therapies by specifically binding to B cell markers, making them suitable for precision treatment in hematologic malignancies. They enhance therapeutic effectiveness by enabling selective targeting of cancerous B cells, improving patient outcomes and minimizing off target effects. For instance, in December 2024, according to the American Society of Gene Cell Therapy ASGCT, a US based non profit medical and scientific organization, the Food and Drug Administration approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the increasing demand for targeted therapeutics is driving the growth of the cluster of differentiation CD 79a antibody market.
Major companies operating in the cluster of differentiation CD 79a antibody market are focusing on developing advanced solutions such as flexible multiplex immunohistochemistry IHC assays to accelerate research, enhance data quality, and reduce manual workflow complexity. Flexible multiplex IHC refers to advanced laboratory techniques that allow for the simultaneous detection of multiple biomarkers on a single tissue sample while preserving spatial context. For instance, in September 2023, Cell Signaling Technology CST, a US based biotechnology company, launched the SignalStar Multiplex IHC platform. This spatial biology solution is a flexible antibody based platform that enables highly multiplexed experiments for up to eight plex amplification in two days. It includes integrated panel design support and optimized protocols, enabling seamless biomarker detection and data generation without extensive optimization. It improves diagnostic accuracy, throughput, and spatial resolution in tissue based analysis, marking an important advancement in the CD79a antibody field.
In December 2023, Danaher Corporation, a US based biotechnology company, acquired Abcam plc for five point seven billion dollars. With this acquisition, Danaher aims to strengthen its position in the life sciences and proteomics market, expanding its portfolio of research reagents, antibodies, and related solutions for drug discovery and diagnostics. Abcam plc is a UK based life sciences company offering CD79a antibodies for immunology and cancer research.
Major companies operating in the cluster of differentiation (cd) 79a antibody market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, GenScript Biotech Corporation, Cell Signaling Technology Inc., Sino Biological Inc., Proteintech Group Inc., Santa Cruz Biotechnology Inc., OriGene Technologies Inc., GeneTex Inc., Abnova Corporation, RayBiotech Life Inc., Wuhan Fine Biotech Co. Ltd. (commonly known as FineTest), Aviva Systems Biology Corporation, EXBIO Praha a.s., NSJ Bioreagents Inc., Boster Biological Technology Co. Ltd., Bioss Antibodies Inc.
North America was the largest region in the cluster of differentiation (CD) 79a antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cluster of differentiation (CD) 79a antibody report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cluster of differentiation (CD) 79a antibody market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cluster of differentiation (CD) 79a antibody market consists of sales of primary antibodies, secondary antibodies, antibody conjugates, recombinant proteins, assay kits, and detection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cluster Of Differentiation (CD) 79a Antibody Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cluster of differentiation (cd) 79a antibody market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cluster of differentiation (cd) 79a antibody ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cluster of differentiation (cd) 79a antibody market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3) By Recombinant Antibodies: Single Chain Variable Fragment Antibodies; Fragment Antigen Binding Antibodies; Bispecific Antibodies; Nanobodies; Engineered Full Length Antibodies
Companies Mentioned: Thermo Fisher Scientific Inc.; Becton, Dickinson and Company; Bio-Rad Laboratories Inc.; Bio-Techne Corporation; Miltenyi Biotec B.V. & Co. KG; GenScript Biotech Corporation; Cell Signaling Technology Inc.; Sino Biological Inc.; Proteintech Group Inc.; Santa Cruz Biotechnology Inc.; OriGene Technologies Inc.; GeneTex Inc.; Abnova Corporation; RayBiotech Life Inc.; Wuhan Fine Biotech Co. Ltd. (commonly known as FineTest); Aviva Systems Biology Corporation; EXBIO Praha a.s.; NSJ Bioreagents Inc.; Boster Biological Technology Co. Ltd.; Bioss Antibodies Inc.
Countries:
Table of Contents
1. Executive Summary
2. Cluster Of Differentiation (CD) 79a Antibody Market Characteristics
3. Cluster Of Differentiation (CD) 79a Antibody Market Trends And Strategies
4. Cluster Of Differentiation (CD) 79a Antibody Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cluster Of Differentiation (CD) 79a Antibody Growth Analysis And Strategic Analysis Framework
5.1. Global Cluster Of Differentiation (CD) 79a Antibody PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cluster Of Differentiation (CD) 79a Antibody Market Growth Rate Analysis
5.4. Global Cluster Of Differentiation (CD) 79a Antibody Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cluster Of Differentiation (CD) 79a Antibody Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cluster Of Differentiation (CD) 79a Antibody Total Addressable Market (TAM)
6. Cluster Of Differentiation (CD) 79a Antibody Market Segmentation
6.1. Global Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
6.2. Global Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Western Blotting
Immunohistochemistry
Flow Cytometry
Enzyme-Linked Immunosorbent Assay (ELISA)
6.3. Global Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct Sales
Distributors
Online Sales
6.4. Global Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biotechnology Companies
Pharmaceutical Companies
Academic And Research Institutes
Diagnostic Laboratories
6.5. Global Cluster Of Differentiation (CD) 79a Antibody Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mouse Derived Antibodies
Rabbit Derived Antibodies
Human Derived Antibodies
Chimeric Antibodies
Humanized Antibodies
6.6. Global Cluster Of Differentiation (CD) 79a Antibody Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Goat Derived Antibodies
Rabbit Derived Antibodies
Sheep Derived Antibodies
Donkey Derived Antibodies
Horse Derived Antibodies
6.7. Global Cluster Of Differentiation (CD) 79a Antibody Market, Sub-Segmentation Of Recombinant Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Chain Variable Fragment Antibodies
Fragment Antigen Binding Antibodies
Bispecific Antibodies
Nanobodies
Engineered Full Length Antibodies
7. Cluster Of Differentiation (CD) 79a Antibody Market Regional And Country Analysis
7.1. Global Cluster Of Differentiation (CD) 79a Antibody Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cluster Of Differentiation (CD) 79a Antibody Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cluster Of Differentiation (CD) 79a Antibody Market
8.1. Asia-Pacific Cluster Of Differentiation (CD) 79a Antibody Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cluster Of Differentiation (CD) 79a Antibody Market
9.1. China Cluster Of Differentiation (CD) 79a Antibody Market Overview
9.2. China Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cluster Of Differentiation (CD) 79a Antibody Market
10.1. India Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cluster Of Differentiation (CD) 79a Antibody Market
11.1. Japan Cluster Of Differentiation (CD) 79a Antibody Market Overview
11.2. Japan Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cluster Of Differentiation (CD) 79a Antibody Market
12.1. Australia Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cluster Of Differentiation (CD) 79a Antibody Market
13.1. Indonesia Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cluster Of Differentiation (CD) 79a Antibody Market
14.1. South Korea Cluster Of Differentiation (CD) 79a Antibody Market Overview
14.2. South Korea Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cluster Of Differentiation (CD) 79a Antibody Market
15.1. Western Europe Cluster Of Differentiation (CD) 79a Antibody Market Overview
15.2. Western Europe Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cluster Of Differentiation (CD) 79a Antibody Market
16.1. UK Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cluster Of Differentiation (CD) 79a Antibody Market
17.1. Germany Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cluster Of Differentiation (CD) 79a Antibody Market
18.1. France Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cluster Of Differentiation (CD) 79a Antibody Market
19.1. Italy Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cluster Of Differentiation (CD) 79a Antibody Market
20.1. Spain Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cluster Of Differentiation (CD) 79a Antibody Market
21.1. Eastern Europe Cluster Of Differentiation (CD) 79a Antibody Market Overview
21.2. Eastern Europe Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cluster Of Differentiation (CD) 79a Antibody Market
22.1. Russia Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cluster Of Differentiation (CD) 79a Antibody Market
23.1. North America Cluster Of Differentiation (CD) 79a Antibody Market Overview
23.2. North America Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cluster Of Differentiation (CD) 79a Antibody Market
24.1. USA Cluster Of Differentiation (CD) 79a Antibody Market Overview
24.2. USA Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cluster Of Differentiation (CD) 79a Antibody Market
25.1. Canada Cluster Of Differentiation (CD) 79a Antibody Market Overview
25.2. Canada Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cluster Of Differentiation (CD) 79a Antibody Market
26.1. South America Cluster Of Differentiation (CD) 79a Antibody Market Overview
26.2. South America Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cluster Of Differentiation (CD) 79a Antibody Market
27.1. Brazil Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cluster Of Differentiation (CD) 79a Antibody Market
28.1. Middle East Cluster Of Differentiation (CD) 79a Antibody Market Overview
28.2. Middle East Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cluster Of Differentiation (CD) 79a Antibody Market
29.1. Africa Cluster Of Differentiation (CD) 79a Antibody Market Overview
29.2. Africa Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cluster Of Differentiation (CD) 79a Antibody Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cluster Of Differentiation (CD) 79a Antibody Market Competitive Landscape And Company Profiles
30.1. Cluster Of Differentiation (CD) 79a Antibody Market Competitive Landscape
30.2. Cluster Of Differentiation (CD) 79a Antibody Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Miltenyi Biotec B.V. & Co. KG Overview, Products and Services, Strategy and Financial Analysis
31. Cluster Of Differentiation (CD) 79a Antibody Market Other Major And Innovative Companies
31.1. GenScript Biotech Corporation
31.2. Cell Signaling Technology Inc.
31.3. Sino Biological Inc.
31.4. Proteintech Group Inc.
31.5. Santa Cruz Biotechnology Inc.
31.6. OriGene Technologies Inc.
31.7. GeneTex Inc.
31.8. Abnova Corporation
31.9. RayBiotech Life Inc.
31.10. Wuhan Fine Biotech Co. Ltd. (commonly known as FineTest)
31.11. Aviva Systems Biology Corporation
31.12. EXBIO Praha a.s.
31.13. NSJ Bioreagents Inc.
31.14. Boster Biological Technology Co. Ltd.
31.15. Bioss Antibodies Inc.
32. Global Cluster Of Differentiation (CD) 79a Antibody Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cluster Of Differentiation (CD) 79a Antibody Market
34. Recent Developments In The Cluster Of Differentiation (CD) 79a Antibody Market
35. Cluster Of Differentiation (CD) 79a Antibody Market High Potential Countries, Segments and Strategies
35.1 Cluster Of Differentiation (CD) 79a Antibody Market In 2029 - Countries Offering Most New Opportunities
35.2 Cluster Of Differentiation (CD) 79a Antibody Market In 2029 - Segments Offering Most New Opportunities
35.3 Cluster Of Differentiation (CD) 79a Antibody Market In 2029 - Growth Strategies
